Home/Pipeline/GraMOS for High-Throughput Screening

GraMOS for High-Throughput Screening

Drug Discovery (e.g., ion channel modulators)

Technology DevelopmentActive

Key Facts

Indication
Drug Discovery (e.g., ion channel modulators)
Phase
Technology Development
Status
Active
Company

About Nanotools Bioscience

Nanotools Bioscience is a private, pre-revenue platform company developing a novel optical stimulation technology for drug discovery. Its core innovation, Graphene-Mediated Optical Stimulation (GraMOS), uses graphene to convert light into precise electrical signals that depolarize cell membranes, enabling all-optical, high-throughput functional assays on genetically intact cells. This addresses a key bottleneck in early-stage drug screening by providing a scalable, non-genetic method to trigger and measure cellular activity. The company appears to be in a technology development and early collaboration phase, targeting research and pharmaceutical partners.

View full company profile